The exploitation of the 340B drug pricing program is driving up healthcare costs and threatening the viability of small businesses.
2 reports, 1 independent
Updated Aug 11
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The exploitation of the 340B drug pricing program is driving up healthcare costs and threatening the viability of small businesses.
Keep exploring
Coverage
Newest first; wire copies grouped- gilmermirror.comOp-Ed: America’s Small Businesses Can’t Afford 340B Abuse